Overview

Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Phase:
Phase 3
Details
Lead Sponsor:
University of Kansas Medical Center
Treatments:
Bupropion